Invesco Ltd. Dyne Therapeutics, Inc. Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 259,854 shares of DYN stock, worth $7.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

259,854

Previous 250,040 3.92%

Holding current value

$7.4 Million

Previous $7.1 Million 29.19%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$23.65 - $35.63 $232,101 - $349,672	9,814 Added 3.92%	259,854 $9.17 Million
Q1 2024 May 14, 2024	BUY	$13.06 - $29.18 $2.28 Million - $5.1 Million	174,868 Added 232.62%	250,040 $7.1 Million
Q4 2023 Feb 12, 2024	SELL	$6.62 - $13.64 $127,256 - $262,201	-19,223 Reduced 20.36%	75,172 $999,000
Q3 2023 Nov 13, 2023	BUY	$8.6 - $12.18 $218,044 - $308,811	25,354 Added 36.72%	94,395 $845,000
Q2 2023 Aug 11, 2023	SELL	$8.53 - $14.28 $1.47 Million - $2.45 Million	-171,853 Reduced 71.34%	69,041 $776,000
Q1 2023 May 12, 2023	BUY	$10.88 - $15.0 $1.15 Million - $1.59 Million	106,116 Added 78.73%	240,894 $2.78 Million
Q4 2022 Feb 13, 2023	SELL	$9.37 - $13.8 $27,725 - $40,834	-2,959 Reduced 2.15%	134,778 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$7.2 - $15.17 $910,015 - $1.92 Million	126,391 Added 1113.97%	137,737 $1.75 Million
Q2 2022 Aug 15, 2022	SELL	$4.36 - $10.5 $1,534 - $3,696	-352 Reduced 3.01%	11,346 $78,000
Q1 2022 May 16, 2022	BUY	$6.52 - $12.27 $1,903 - $3,582	292 Added 2.56%	11,698 $112,000
Q4 2021 Feb 14, 2022	SELL	$11.89 - $16.07 $1,605 - $2,169	-135 Reduced 1.17%	11,406 $136,000
Q3 2021 Nov 15, 2021	BUY	$15.6 - $21.46 $24,757 - $34,057	1,587 Added 15.94%	11,541 $187,000
Q2 2021 Aug 17, 2021	BUY	$15.94 - $22.33 $158,666 - $222,272	9,954 New	9,954 $209,000

Others Institutions Holding DYN

# of Institutions

204

Shares Held

105M

Call Options Held

82.7K

Put Options Held

24.8K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.47B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account